Sign in
Taking people in United StatesPhase 1

Tests stem cells from umbilical cord or placenta for polycystic ovary syndrome

Tests donor stem cells given into a vein in adults with polycystic ovary syndrome.

Key facts

Who runs it
The Foundation for Orthopaedics and Regenerative Medicine
Where
Naples, United StatesSee the siteAlso in 1 other country, 1 site
Trial code
Registry title
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for PCOS
Status
Recruiting
Phase
Phase 1
People taking part
20 people, planned
Started
16 Nov 2023
Expected to end
16 Nov 2027
Type of study
Interventional
Treatments tested
  • Cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells
Record updated
20 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women aged 18 or older with polycystic ovary syndrome (PCOS) shown on an ultrasound. It tests stem cells given through a vein.

Age
18 years or older
Sex
Women only
Disease stage
Polycystic ovary syndrome shown on an ultrasound
Earlier treatment
Not stated in the record. People with a previous organ transplant cannot join.

Main reasons for not taking part

  • Active infection
  • Active cancer
  • Chronic failure of several organs
  • Pregnancy
  • Previous organ transplant

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Ultrasound documented poly cystic ovary syndrome

Who cannot take part

  • Continued drug abuse
  • Previous organ transplant
  • Active infection
  • Active cancer
  • Chronic multisystem organ failure
  • Medical condition that would (based on the opinion of the investigator) compromise patient's safety
  • Hypersensitivity to sulfur
  • Clinically significant abnormalities on pre-treatment laboratory evaluation
  • Pregnancy
  • Inability to supply proper informed consent

Where in United States

Also in 1 other country, 1 site

  • Prodromos Stem Cell InstituteNaples, United StatesContact: Chadwick Prodromos, MDTaking people

About the trial

What the trial wants to find out

This trial will study the safety and efficacy of cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells delivered intravenously for the treatment of Polycystic Ovary Syndrome.

The group in the trial

  • Treatment GroupTreatment being tested

    Intravenous infusion

    Treatment: Cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for the Treatment of Polycystic Ovary Syndrome
Plain-language title
Tests stem cells from umbilical cord or placenta for polycystic ovary syndromeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
20 October 2026